LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor

Abstract

Lung cancer is featured with high mortality, with a 15% five-year survival rate worldwide. Genetic alterations, such as loss of function of tumor suppressor genes, frequently contribute to lung cancer initiation, progression and metastasis. Liver kinase B1 (LKB1), as a serine/threonine kinase and tumor suppressor, is frequently mutated and inactivated in non-small cell lung cancer (NSCLC). Recent studies have provided strong evidences that LKB1 loss promotes lung cancerigenesis process, especially lung cancer progression and metastasis. This review will summarize recent progress on how LKB1 modulates the process of lung cancerigenesis, emphasizing on LKB1 downstream signaling pathways and biological functions. We will further discuss the potential development of prognostic biomarkers or therapeutic targets in lung cancer clinic based on the molecular alteration associated with deregulated LKB1 signaling.

Keywords

liver kinase B1 / lung cancer / tumor suppressor

References

[1] Achiwa, H., Yatabe, Y., Hida, T., Kuroishi, T., Kozaki, K., Nakamura, S., Ogawa, M., Sugiura, T., Mitsudomi, T., and Takahashi, T. (1999). Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res 5, 1001-1005 .10353732
[2] Alessi, D.R., Sakamoto, K., and Bayascas, J.R. (2006). LKB1-dependent signaling pathways. Annu Rev Biochem 75, 137-163 .16756488
[3] Alexander, A., Cai, S.L., Kim, J., Nanez, A., Sahin, M., MacLean, K.H., Inoki, K., Guan, K.L., Shen, J., Person, M.D., (2010). ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 107, 4153-4158 .20160076
[4] Avizienyte, E., Loukola, A., Roth, S., Hemminki, A., Tarkkanen, M., Salovaara, R., Arola, J., Bützow, R., Husgafvel-Pursiainen, K., Kokkola, A., (1999). LKB1 somatic mutations in sporadic tumors. Am J Pathol 154, 677-681 .10079245
[5] Baas, A.F., Kuipers, J., van der Wel, N.N., Batlle, E., Koerten, H.K., Peters, P.J., and Clevers, H.C. (2004). Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116, 457-466 .15016379
[6] Carretero, J., Medina, P.P., Blanco, R., Smit, L., Tang, M., Roncador, G., Maestre, L., Conde, E., Lopez-Rios, F., Clevers, H.C., (2007). Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer. Oncogene 26, 1616-1625 .16953221
[7] Carretero, J., Medina, P.P., Pio, R., Montuenga, L.M., and Sanchez-Cespedes, M. (2004). Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene. Oncogene 23, 4037-4040 .15021901
[8] Carretero, J., Shimamura, T., Rikova, K., Jackson, A.L., Wilkerson, M.D., Borgman, C.L., Buttarazzi, M.S., Sanofsky, B.A., McNamara, K.L., Brandstetter, K.A., (2010). Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell 17, 547-559 .20541700
[9] Contreras, C.M., Akbay, E.A., Gallardo, T.D., Haynie, J.M., Sharma, S., Tagao, O., Bardeesy, N., Takahashi, M., Settleman, J., Wong, K.K., (2008). Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy. Dis Models & Mechan 3, 181-193 .
[10] Contreras, C.M., Gurumurthy, S., Haynie, J.M., Shirley, L.J., Akbay, E.A., Wingo, S.N., Schorge, J.O., Broaddus, R.R., Wong, K.K., Bardeesy, N., (2008). Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas. Cancer Res 68, 759-766 .18245476
[11] Ding, L., Getz, G., Wheeler, D.A., Mardis, E.R., McLellan, M.D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D.M., Morgan, M.B., (2008). Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069-1075 .18948947
[12] Forcet, C., Etienne-Manneville, S., Gaude, H., Fournier, L., Debilly, S., Salmi, M., Baas, A., Olschwang, S., Clevers, H., and Billaud, M. (2005). Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity. Hum Mol Genet 14, 1283-1292 .15800014
[13] Gan, B., Hu, J., Jiang, S., Liu, Y., Sahin, E., Zhuang, L., Fletcher-Sananikone, E., Colla, S., Wang, Y.A., Chin, L., (2010). Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 468, 701-704 .21124456
[14] Gandhi, L., McNamara, K.L., Li, D., Borgman, C.L., McDermott, U., Brandstetter, K.A., Padera, R.F., Chirieac, L.R., Settleman, J.E., and Wong, K.K. (2009). Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis. Cancer Pre Res (Phila), Pa 2, 330-337 .
[15] Gao, B., Sun, Y., Zhang, J., Ren, Y., Fang, R., Han, X., Shen, L., Liu, X.Y., Pao, W., Chen, H., (2010a). Spectrum of LKB1, EGFR, and KRAS mutations in chinese lung adenocarcinomas. J Thorac Oncol 5, 1130-1135 .20559149
[16] Gao, Y., Xiao, Q., Ma, H., Li, L., Liu, J., Feng, Y., Fang, Z., Wu, J., Han, X., Zhang, J., (2010b). LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc Natl Acad Sci U S A 107, 18892-18897 .20956321
[17] Giardiello, F.M., Welsh, S.B., Hamilton, S.R., Offerhaus, G.J., Gittelsohn, A.M., Booker, S.V., Krush, A.J., Yardley, J.H., and Luk, G.D. (1987). Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316, 1511-1514 .3587280
[18] Gurumurthy, S., Xie, S.Z., Alagesan, B., Kim, J., Yusuf, R.Z., Saez, B., Tzatsos, A., Ozsolak, F., Milos, P., Ferrari, F., (2010). The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 468, 659-663 .21124451
[19] Hemminki, A. (1999). The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol Life Sci 55, 735-750 .10379360
[20] Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., H?glund, P., (1998). A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391, 184-187 .9428765
[21] Hezel, A.F., Gurumurthy, S., Granot, Z., Swisa, A., Chu, G.C., Bailey, G., Dor, Y., Bardeesy, N., and Depinho, R.A. (2008). Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol Cell Biol 28, 2414-2425 .18227155
[22] Huang, Q., Wu, Y.T., Tan, H.L., Ong, C.N., and Shen, H.M. (2009). A novel function of poly(ADP-ribose) polymerase-1 in modulation of autophagy and necrosis under oxidative stress. Cell Death Differ 16, 264-277 .18974775
[23] Inge, L.J., Coon, K.D., Smith, M.A., and Bremner, R.M. (2009). Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose. J Thorac Cardiovasc Surg 137, 580-586 .19258070
[24] Jackson, E.L., Willis, N., Mercer, K., Bronson, R.T., Crowley, D., Montoya, R., Jacks, T., and Tuveson, D.A. (2001). Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15, 3243-3248 .11751630
[25] Jenne, D.E., Reimann, H., Nezu, J., Friedel, W., Loff, S., Jeschke, R., Müller, O., Back, W., and Zimmer, M. (1998). Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18, 38-43 .9425897
[26] Ji, H., Ramsey, M.R., Hayes, D.N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M.C., Shimamura, T., Perera, S.A., (2007). LKB1 modulates lung cancer differentiation and metastasis. Nature 448, 807-810 .17676035
[27] Jimenez, A.I., Fernandez, P., Dominguez, O., Dopazo, A., and Sanchez-Cespedes, M. (2003). Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3′-phosphate kinase/PTEN pathway. Cancer Res 63, 1382-1388 .12649203
[28] Jones, R.G., Plas, D.R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M.J., and Thompson, C.B. (2005). AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18, 283-293 .15866171
[29] Karuman, P., Gozani, O., Odze, R.D., Zhou, X.C., Zhu, H., Shaw, R., Brien, T.P., Bozzuto, C.D., Ooi, D., Cantley, L.C., (2001). The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell 7, 1307-1319 .11430832
[30] Katajisto, P., Vallenius, T., Vaahtomeri, K., Ekman, N., Udd, L., Tiainen, M., and M?kel?, T.P. (2007). The LKB1 tumor suppressor kinase in human disease. Biochim Biophys Acta 1775, 63-75 .17010524
[31] Keith, B., and Simon, M.C. (2007). Hypoxia-inducible factors, stem cells, and cancer. Cell 129, 465-472 .17482542
[32] Kemphues, K.J., Priess, J.R., Morton, D.G., and Cheng, N.S. (1988). Identification of genes required for cytoplasmic localization in early C. elegans embryos. Cell 52, 311-320 .3345562
[33] Koivunen, J.P., Kim, J., Lee, J., Rogers, A.M., Park, J.O., Zhao, X., Naoki, K., Okamoto, I., Nakagawa, K., Yeap, B.Y., (2008). Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer 99, 245-252 .18594528
[34] Lee, J.H., Koh, H., Kim, M., Kim, Y., Lee, S.Y., Karess, R.E., Lee, S.H., Shong, M., Kim, J.M., Kim, J., (2007). Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 447, 1017-1020 .17486097
[35] Liang, J., Shao, S.H., Xu, Z.X., Hennessy, B., Ding, Z., Larrea, M., Kondo, S., Dumont, D.J., Gutterman, J.U., Walker, C.L., (2007). The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 9, 218-224 .17237771
[36] Mahoney, C.L., Choudhury, B., Davies, H., Edkins, S., Greenman, C., Haaften, G., Mironenko, T., Santarius, T., Stevens, C., Stratton, M.R., (2009). LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition. Br J Cancer 100, 370-375 .19165201
[37] Marignani, P.A., Kanai, F., and Carpenter, C.L. (2001). LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J Biol Chem 276, 32415-32418 .11445556
[38] Matsumoto, S., Iwakawa, R., Takahashi, K., Kohno, T., Nakanishi, Y., Matsuno, Y., Suzuki, K., Nakamoto, M., Shimizu, E., Minna, J.D., (2007). Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene 26, 5911-5918 .17384680
[39] McCarthy, A., Lord, C.J., Savage, K., Grigoriadis, A., Smith, D.P., Weigelt, B., Reis-Filho, J.S., and Ashworth, A. (2009). Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formation. J Pathol 219, 306-316 .19681070
[40] Memmott, R.M., Gills, J.J., Hollingshead, M., Powers, M.C., Chen, Z., Kemp, B., Kozikowski, A., and Dennis, P.A. (2008). Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells. Cancer Res 68, 580-588 .18199555
[41] Mita, M., Sankhala, K., Abdel-Karim, I., Mita, A., and Giles, F. (2008). Deforolimus (AP23573) a novel mTOR inhibitor in clinical development. Expert Opin Investig Drugs 17, 1947-1954 .19012509
[42] Miyoshi, H., Nakau, M., Ishikawa, T.O., Seldin, M.F., Oshima, M., and Taketo, M.M. (2002). Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res 62, 2261-2266 .11956081
[43] Moren, A., Raja, E., Heldin, C.H., and Moustakas, A. (2011). Negative regulation of TGF{beta} signaling by the kinase LKB1 and the scaffolding protein LIP1. J Biol Chem 286(1): 341-353 .
[44] Nakada, D., Saunders, T.L., and Morrison, S.J. (2010). Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468, 653-658 .21124450
[45] Nakau, M., Miyoshi, H., Seldin, M.F., Imamura, M., Oshima, M., and Taketo, M.M. (2002). Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res 62, 4549-4553 .12183403
[46] O’Neill, G.M., Seo, S., Serebriiskii, I.G., Lessin, S.R., and Golemis, E.A. (2007). A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9. Cancer Res 67, 8975-8979 .17908996
[47] Onozato, R., Kosaka, T., Achiwa, H., Kuwano, H., Takahashi, T., Yatabe, Y., and Mitsudomi, T. (2007). LKB1 gene mutations in Japanese lung cancer patients. Cancer Sci 98, 1747-1751 .17711506
[48] Rodriguez-Nieto, S., and Sanchez-Cespedes, M. (2009). BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer. Carcinogenesis 30, 547-554 .19176640
[49] Roy, B.C., Kohno, T., Iwakawa, R., Moriguchi, T., Kiyono, T., Morishita, K., Sanchez-Cespedes, M., Akiyama, T., and Yokota, J. (2010). Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells. Lung Cancer 70, 136-145 .20207041
[50] Sanchez-Cespedes, M. (2007). A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 26, 7825-7832 .17599048
[51] Sanchez-Cespedes, M., Parrella, P., Esteller, M., Nomoto, S., Trink, B., Engles, J.M., Westra, W.H., Herman, J.G., and Sidransky, D. (2002). Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 62, 3659-3662 .12097271
[52] Shackelford, D.B., and Shaw, R.J. (2009). The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9, 563-575 .19629071
[53] Shaw, R.J., Kosmatka, M., Bardeesy, N., Hurley, R.L., Witters, L.A., DePinho, R.A., and Cantley, L.C. (2004). The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 101, 3329-3335 .14985505
[54] Sobottka, S.B., Haase, M., Fitze, G., Hahn, M., Schackert, H.K., and Schackert, G. (2000). Frequent loss of heterozygosity at the 19p13.3 locus without LKB1/STK11 mutations in human carcinoma metastases to the brain. J Neurooncol 49, 187-195 .11212897
[55] Spano, J.P., Chouahnia, K., and Morere, J.F. (2004). Cyclooxygenase 2 inhibitors and lung carcinoma. Bull Cancer 91(Suppl 2), S109-S112 .
[56] Sun, Y., Ren, Y., Fang, Z., Li, C., Fang, R., Gao, B., Han, X., Tian, W., Pao, W., Chen, H., (2010). Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases. J Clin Oncol 28, 4616-4620 .20855837
[57] Tomlinson, I.P., and Houlston, R.S. (1997). Peutz-Jeghers syndrome. J Med Genet 34, 1007-1011 .9429144
[58] Upadhyay, S., Liu, C., Chatterjee, A., Hoque, M.O., Kim, M.S., Engles, J., Westra, W., Trink, B., Ratovitski, E., and Sidransky, D. (2006). LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer. Cancer Res 66, 7870-7879 .16912160
[59] Weir, B.A., Woo, M.S., Getz, G., Perner, S., Ding, L., Beroukhim, R., Lin, W.M., Province, M.A., Kraja, A., Johnson, L.A., (2007). Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893-898 .17982442
[60] Wingo, S.N., Gallardo, T.D., Akbay, E.A., Liang, M.C., Contreras, C.M., Boren, T., Shimamura, T., Miller, D.S., Sharpless, N.E., Bardeesy, N., (2009). Somatic LKB1 mutations promote cervical cancer progression. PLoS One 4, e5137.19340305
[61] Wu, Y., and Zhou, B.P. (2008). New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai) 40, 643-650 .18604456
[62] Zeng, P.Y., and Berger, S.L. (2006). LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation. Cancer Res 66, 10701-10708 .17108107
[63] Zhang, S., Schafer-Hales, K., Khuri, F.R., Zhou, W., Vertino, P.M., and Marcus, A.I. (2008). The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity. Cancer Res 68, 740-748 .18245474